Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01512069
Other study ID # NCCNCS-11-501
Secondary ID
Status Completed
Phase N/A
First received January 4, 2012
Last updated April 23, 2014
Start date October 2011
Est. completion date August 2012

Study information

Verified date April 2014
Source National Cancer Center, Korea
Contact n/a
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Life style interventions that promote exercise and a healthy diet, which have the potential to improve health-related quality of life (HRQOL), may be particularly appropriate for cancer survivors. The previous studies suggested that a key strategy to implement sustainable healthy behavior and improve health was providing appropriate feedback and promoting self-efficacy. Web-based program enables to provide the feedback in a timely manner on a daily basis, to continue the healthy behaviors.

Therefore, the investigators developed a web-based, stage-matched Exercise and Diet Planning program, and whether the program can promote significantly greater changes in behavioral outcomes [goal of exercise (energy expenditure of aerobic exercise ≥ 12.5 kcal/kg/week) and diet (intake of vegetables ≥ 5 serv/day and intake of fruit ≥ 1 serv/day)], stage of changes for exercise and diet, psychosocial outcomes (HRQOL, fatigue, anxiety and depression) and self-efficacy in implementing goal of exercise and diet among breast cancer survivors in Korea was examined.

Hypotheses were following:

1. Survivors of a group participating in a web-based, stage-matched Exercise and Diet Planning program (hereinafter called the 'intervention group') will show a more advanced stage of change for exercise and diet compared to survivors in the control group.

2. The intervention group will show a higher proportion of attaining goal of exercise (or higher level of energy expenditure of aerobic exercise) compared to the control group.

3. The intervention group will show a higher proportion of attaining goal of diet (or higher level of diet quality) compared to the control group.

4. The intervention group will show a better HRQOL level compared to the control group.

5. The intervention group will show a better self-efficacy level compared to the control group.

6. The intervention group will show a lower fatigue level compared to the control group.

7. The intervention group will show less anxiety compared to the control group.

8. The intervention group will show less depression compared to the control group.


Description:

The purpose of the study was to develop a web-based, stage-matched Exercise and Diet Planning program and to examine effects of the program on implementation of exercise and diet, self-efficacy, HRQOL, fatigue, anxiety and depression among breast cancer survivors.

All participants were recruited from two tertiary university hospitals and the National Cancer Center in Korea.


Recruitment information / eligibility

Status Completed
Enrollment 59
Est. completion date August 2012
Est. primary completion date March 2012
Accepts healthy volunteers No
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria:

1. Women aged 20 years and older

2. Histologically confirmed stage 0 to III breast cancer who received curative breast cancer surgery within 12 months since completion of primary cancer treatment and 2 years since diagnosis

3. Serum platelet = 100,000/mm3

4. Serum hemoglobin = 10g/dl

5. Not met one or more behavior goals: i) energy expenditure of aerobic exercise = 12.5 kcal/kg/week; ii) intake of vegetables except kimchi = 5 serv/day and intake of fruit 1-2 serv/day; iii) maintenance of healthy weight (18.5 kg/m2 = BMI < 23 kg/m2)

6. Ability to use internet, and being accessible internet at home

7. Mobile phone user

8. Consent form to participate in the study

Exclusion Criteria:

1. Currently receiving any cancer treatment

2. Conditions that could limit adherence to an unsupervised exercise program such as uncontrolled congestive heart failure or angina, recent myocardial infarction, or breathing difficulties requiring oxygen use or hospitalization; walker or wheelchair use; or plans to have hip or knee replacement

3. Conditions that could interfere with a high vegetable and fruit diet, such as kidney failure or chronic warfarin use

4. Progressive malignant disease or additional primary cancers

5. Infectious condition (body temperature = 37.2? or WBC = 11,000mm3)

6. Inability to use computer or internet

7. Visual and motor dysfunction

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Web-based Health Planner on diet and exercise
URL is closed The program is 12-week program, provides tailored information on the exercise and diet based on the stage of motivational readiness of TTM. The program is designed to allow to plan a regular exercise of 12.5 MET per week and to recommend to eat number of portions from six food groups for balanced diet tailored to individual's BMI, ideal body weight, and calories needed per day. The program provide the feedback based on the achievement of goals of the behaviors.
Non-tailored booklet on exercise and diet
The active control group is provided non-tailored booklet on exercise and diet, whose information is same as web-based program except stage-matching.

Locations

Country Name City State
Korea, Republic of National Cancer Center Gyenggi-do Goyang-si
Korea, Republic of Asan Medical Center Seoul
Korea, Republic of Korea University Anam Hospital Seoul
Korea, Republic of Seoul National University Seoul

Sponsors (4)

Lead Sponsor Collaborator
National Cancer Center, Korea Asan Medical Center, Korea University Anam Hospital, Seoul National University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in numbers of goal behaviors at 3 months The primary outcomes of the study are to achieve goals of healthy behaviors as followed:
i) exercising=12.5kcal/kg/week; ii) eating vegetables=5serv/day and fruits 1-2 serv/day; iii) healthy weight (18.5kg/m2 = BMI < 25kg/m2) The primary outcome of the study is the increased number of goal behaviors.
Baseline (pre-treatment) and after 12 weeks of intervention (post-treatment) Yes
Secondary Change from baseline in Stage of Change at 3 months Stage of motivational readiness for exercise and diet based on the established TTM Baseline, 1month, 2 month, 3 month after starting the intervention Yes
Secondary Change from baseline in self-efficacy at 3 months The self-efficacy for exercising=12.5kcal/kg/week, eating vegetables=5serv/day and fruits 1-2 serv/day Baseline, 1month, 2 month, 3 month after starting the intervention Yes
Secondary Change from baseline in psychosocial outcomes at 3 months The psychosocial outcomes are HRQOL, fatigue, anxiety and depression Baseline, 1month, 2 month, 3 month after starting the intervention Yes
Secondary Change from baseline in Diet quality at 3 months Diet quality based on a three-day diet recall and the Diet Quality Index (DQI) revised for the Korean population Baseline, 1month, 2 month, 3 month after starting the intervention Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2